Ruxolitinib for Cancer Cachexia

Clinical trial NCT04906746 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04906746
Sponsor: Tu Dan
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Stage IV Non-small Cell Lung Cancer Cachexia

Start date: 2022-02-23
Primary completion: 2024-09-27
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.